LifeBond

LifeBond

Manufactures medical devices for biosurgery and tissue repair in an effort to save lives and reduce postoperative complications. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD167—250m (Dealroom.co estimates Aug 2015.)
Company register number 513914895
Keisarya Israel (HQ)
  • Edit
DateInvestorsAmountRound

N/A

Seed

$1.5m

Series A

$8.0m

Series B

$20.0m

Series C

$27.0m

Series D

N/A

Acquisition
Total FundingAUD87.3m

Recent News about LifeBond

Edit
More about LifeBondinfo icon
Edit

LifeBond is a medical technology company specializing in advanced hemostatic solutions designed to control surgical bleeding and improve patient outcomes. Operating in the healthcare and medical devices market, LifeBond serves hospitals, surgical centers, and healthcare professionals who require reliable and effective bleeding control products. The company's business model revolves around the development, manufacturing, and distribution of its proprietary hemostatic products, which generate revenue through direct sales and partnerships with medical distributors. LifeBond's innovative products are designed to enhance surgical safety, reduce complications, and improve overall patient care, making it a valuable player in the medical technology industry.

Keywords: hemostatic solutions, surgical bleeding, patient safety, medical technology, healthcare, surgical centers, bleeding control, medical devices, innovation, patient care.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.